To examine the direct role of T-αFGL2 in the encounter between T cells and tumor cells, we cocultured DBT glioma cells with T-Ctr or T-αFGL2 cells for 72 h ex vivo, sorted CD8+ T cells via flow cytometry, and conducted next-generation sequencing of the CD8+ T cells. The gene discussed is CD8A; the disease is glioma.